- Home
- GSBC vs QURE Comparison
GSBC vs QURE Comparison
Compare GSBC & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSBC
- QURE
- Stock Information
- Founded
- GSBC 1923
- QURE 1998
- Country
- GSBC United States
- QURE Netherlands
- Employees
- GSBC N/A
- QURE N/A
- Industry
- GSBC Major Banks
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- GSBC Finance
- QURE Health Care
- Exchange
- GSBC Nasdaq
- QURE Nasdaq
- Market Cap
- GSBC 665.7M
- QURE 725.4M
- IPO Year
- GSBC N/A
- QURE 2007
- Fundamental
- Price
- GSBC $59.02
- QURE $13.96
- Analyst Decision
- GSBC Hold
- QURE Strong Buy
- Analyst Count
- GSBC 2
- QURE 10
- Target Price
- GSBC $59.50
- QURE $37.20
- AVG Volume (30 Days)
- GSBC 95.4K
- QURE 1.1M
- Earning Date
- GSBC 07-16-2025
- QURE 07-31-2025
- Dividend Yield
- GSBC 2.70%
- QURE N/A
- EPS Growth
- GSBC 10.52
- QURE N/A
- EPS
- GSBC 5.60
- QURE N/A
- Revenue
- GSBC $219,572,000.00
- QURE $20,201,000.00
- Revenue This Year
- GSBC N/A
- QURE N/A
- Revenue Next Year
- GSBC $1.04
- QURE $278.91
- P/E Ratio
- GSBC $10.57
- QURE N/A
- Revenue Growth
- GSBC N/A
- QURE 6.30
- 52 Week Low
- GSBC $47.58
- QURE $4.45
- 52 Week High
- GSBC $68.02
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- GSBC 48.83
- QURE 43.44
- Support Level
- GSBC $60.21
- QURE $14.03
- Resistance Level
- GSBC $62.90
- QURE $15.16
- Average True Range (ATR)
- GSBC 1.45
- QURE 0.61
- MACD
- GSBC -0.08
- QURE -0.02
- Stochastic Oscillator
- GSBC 25.38
- QURE 27.27
About GSBC Great Southern Bancorp Inc.
Great Southern Bancorp Inc is a bank holding company. It is principally engaged in the business of originating residential and commercial real estate loans, construction loans, commercial business loans, and consumer loans. The bank provides various services such as Business Banking, Merchant Services, Debit and Credit cards, Online Banking, Mobile Banking, VIP Banking, Overdraft Protection, and various other related services. It operates into a single segment which is Community Banking.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.